MORGAN MARHEFKA: Open Payments
NPI 1164900676 · MT ARLINGTON, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$356 in 22 payments from 5 companies in 2025. Trend: 2023 $67 · 2024 $164 · 2025 $356
Food & beverage: $356
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 11 | $167 |
| Optinose US, Inc. | 7 | $122 |
| GlaxoSmithKline, LLC. | 2 | $33 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $19 |
| Paratek Pharmaceuticals, Inc. | 1 | $15 |
Products named: DUPIXENT, Xhance, NUCALA, NEFFY.
Industry payments across NJ — which companies pay providers there.
